A maritime company is involved and a consultation has been launched. The vessel would be powered by a combination of electric ...
Robust, Consistent Phase 3 Data and Real-World Evidence Outcomes Support ANX005 as Potential First Targeted Therapy for GBS; Pre-BLA Meeting ...
At Mobile World Congress 2025, the company announced four different proof-of-concept add-ons that may or may not ever be ...